iSOFT in agreement with ML Park (Russia)
iSOFT Deutschland has strengthened its position in Russia’s healthcare market after a partnership agreement with ML Park of Moscow to distribute and support iSOFT’s laboratory information systems (LIS). The market in Russia offers huge potential and is set to grow at unprecedented rates. The Russian market for medical technology is worth US$2 billion a year and is growing by about 15 per cent per annum. The ‘National Health Programme’, which was initiated by president Putin (until 2010) provides US$1.7 billion to build 15 specialised health centres. iSOFT has already installed its LabCentre laboratory system at KDL Test, a private laboratory chain with laboratories in Moscow, Omsk, Perm and Krasnodar. ML Park and KDL Test are sister companies and both are subsidiaries of ML Group. iSOFT Deutschland, part of the IBA Health Group
post_id:
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
